MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.280
-0.200 (-5.75%)
At close: Nov 20, 2024, 4:00 PM
3.260
-0.020 (-0.61%)
After-hours: Nov 20, 2024, 7:31 PM EST
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $205.86 million as of November 21, 2024. Its market cap has decreased by -47.90% in one year.
Market Cap
205.86M
Enterprise Value
39.60M
1-Year Change
-47.90%
Ranking
Category
Stock Price
$3.28
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $205.86M, a decrease of -65.71%. That is a compound annual growth rate of -9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 205.90M | -65.49% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| biote | 221.28M |
| Utah Medical Products | 219.40M |
| Genfit | 218.81M |
| SOPHiA GENETICS | 217.25M |
| Molecular Partners AG | 214.31M |
| Zentalis Pharmaceuticals | 213.08M |
| Personalis | 209.21M |
| Sera Prognostics | 208.71M |